Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar NoDoughBro (69.72) Submitted: 10/21/2009 11:39:43 PM : Outperform Start Price: $2.33 CORT Score: +48.37

Gimme drugs...gimme drugs.

Report this Post Reply

Featured Broker Partners


Advertisement